Skip to main content
PMC home page
Gut logoLink to Gut
. 1998 Apr;42(4):560–565. doi: 10.1136/gut.42.4.560

Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening

W Atkin 1, A Hart 1, R Edwards 1, P McIntyre 1, R Aubrey 1, J Wardle 1, S Sutton 1, J Cuzick 1, J Northover 1
PMCID: PMC1727083  PMID: 9616321

Abstract

Background—A multicentre randomised controlled trial to evaluate screening by "once only" flexible sigmoidoscopy (FS) for prevention of bowel cancer is in progress. 
Aims—To pilot the trial protocol examining rates of attendance, yield of neoplasia, and adverse effects. 
Subjects—A total of 3540 subjects aged 55-64 years in Welwyn Garden City (WGC) and 19 706 in Leicester (LE). 
Methods—Subjects responding positively to an "interest in screening" questionnaire were randomised to invitation for screening or control arms. Small polyps were removed during screening. Colonoscopy was undertaken for high risk polyps (more than two adenomas, size at least 1 cm, villous histology, severe dysplasia, or malignancy). The remainder were discharged. 
Results—In WGC and LE respectively, 59% and 61% indicated an interest in screening, of which 74% and 75% attended. Adenomas were detected in 10% and 9%, respectively, and cancers in 7 per 1000 (in both centres), 55% at Dukes's stage A. The colonoscopy referral rate was 6% in both centres. Mild, short lived bleeding occurred in 3%. One person died following surgery. 
Conclusions—Compliance rates, yield of adenomas, and referral rate for colonoscopy were as expected, but cancer detection rates were higher. Adverse effects following sigmoidoscopy or colonoscopy were mild and transient, but there was one postoperative death. A randomised trial is necessary to evaluate fully the risks and benefits of this intervention. 



Keywords: screening; colorectal cancer; adenomas; sigmoidoscopy; endoscopy; randomised trial

Full Text

The Full Text of this article is available as a PDF (124.5 KB).

Figure 1 .

Figure 1

Open in a new tab

Two stage screening procedure. 


Figure 2 .

Figure 2

Open in a new tab

Follow up after flexible sigmoidoscopy. 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkin W. S., Cuzick J., Northover J. M., Whynes D. K. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993 Mar 20;341(8847):736–740. doi: 10.1016/0140-6736(93)90499-7. [DOI] [PubMed] [Google Scholar]
  2. Gatteschi B., Costantini M., Bruzzi P., Merlo F., Torcoli R., Nicolo G. Univariate and multivariate analyses of the relationship between adenocarcinoma and solitary and multiple adenomas in colorectal adenoma patients. Int J Cancer. 1991 Oct 21;49(4):509–512. doi: 10.1002/ijc.2910490406. [DOI] [PubMed] [Google Scholar]
  3. Grossman S., Milos M. L., Tekawa I. S., Jewell N. P. Colonoscopic screening of persons with suspected risk factors for colon cancer: II. Past history of colorectal neoplasms. Gastroenterology. 1989 Feb;96(2 Pt 1):299–306. doi: 10.1016/0016-5085(89)91551-5. [DOI] [PubMed] [Google Scholar]
  4. Hardcastle J. D., Chamberlain J. O., Robinson M. H., Moss S. M., Amar S. S., Balfour T. W., James P. D., Mangham C. M. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472–1477. doi: 10.1016/S0140-6736(96)03386-7. [DOI] [PubMed] [Google Scholar]
  5. Jass J. R., Young P. J., Robinson E. M. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut. 1992 Nov;33(11):1508–1514. doi: 10.1136/gut.33.11.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kellokumpu I., Kyllönen L. Multiple adenomas and synchronous hyperplastic polyps as predictors of metachronous colorectal adenomas. Ann Chir Gynaecol. 1991;80(1):30–35. [PubMed] [Google Scholar]
  7. Kronborg O., Fenger C., Olsen J., Jørgensen O. D., Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467–1471. doi: 10.1016/S0140-6736(96)03430-7. [DOI] [PubMed] [Google Scholar]
  8. McCallum R. W., Meyer C. T., Marignani P., Cane E., Contino C. Flexible sigmoidoscopy: diagnostic yield in 1015 patients. Am J Gastroenterol. 1984 Jun;79(6):433–437. [PubMed] [Google Scholar]
  9. Rosevelt J., Frankl H. Colorectal cancer screening by nurse practitioner using 60-cm flexible fiberoptic sigmoidoscope. Dig Dis Sci. 1984 Feb;29(2):161–163. doi: 10.1007/BF01317059. [DOI] [PubMed] [Google Scholar]
  10. Shida H., Yamamoto T. Fiberoptic sigmoidoscopy as the first screening procedure for colorectal neoplasms in an asymptomatic population. Dis Colon Rectum. 1989 May;32(5):404–408. doi: 10.1007/BF02563693. [DOI] [PubMed] [Google Scholar]
  11. Woodman C. B., Prior P., Joseph R., Watson A. Prospects for the secondary prevention of colorectal cancer: screening by flexible sigmoidoscopy? J Med Screen. 1995;2(2):71–78. doi: 10.1177/096914139500200204. [DOI] [PubMed] [Google Scholar]
  12. Zarchy T. M., Ershoff D. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gastroenterology. 1994 Jun;106(6):1501–1504. doi: 10.1016/0016-5085(94)90403-0. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES